Event Details

Verastem at Scientific Data Presentations at AACR

Apr 7, 2013 at 1:00 PM EDT
Title
Verastem at Scientific Data Presentations at AACR
Date / Time
Apr 7, 2013 at 1:00 PM EDT

Date & Time: Sunday, April 7, 2013, from 1:00 to 5:00 p.m. ET
Poster Title: FAK inhibition preferentially attenuates growth of Merlin-negative malignant mesotheliomas: role of cancer stem cells
Abstract Number: 924
Session ID: Experimental and Molecular Therapeutics 3
Location: Hall A-C, Poster Section 38

Date & Time: Sunday, April 7, 2013, from 1:00 to 5:00 p.m. ET
Poster Title: The dual PI3K/mTOR inhibitor VS-5584 preferentially targets cancer stem cells in vitro and in vivo
Abstract Number: 239
Session ID: Tumor Biology 2
Location: Hall A-C, Poster Section 13

Date & Time: Sunday, April 7, 2013, from 1:00 to 5:00 p.m. ET
Poster Title: Pharmacological and genetic inhibition of FAK attenuates cancer stem cell function in vitro and in vivo
Abstract Number: 236
Session ID: Tumor Biology 2
Location: Hall A-C, Poster Section 13

Date & Time: Sunday, April 7, 2013, from 1:00 to 5:00 p.m. ET
Poster Title: Cancer stem cell-selected patient-derived xenograft models with sensitivity to FAK and Pan-PI3K/mTOR inhibitors
Abstract Number: 221
Session ID: Tumor Biology 2
Location: Hall A-C, Poster Section 13

Investor Contact

getty
John Doyle

VP Investor Relations & Finance
781.292.4279
jdoyle@verastem.com

Joe Rayne

Argot Partners
617.340.6075
joseph@argotpartners.com